DEVELOPMENT OF A TRANSDERMAL ADJUSTABLE DOSE PATCH FOR EFFICIENT DRUG DELIVERY

$12,406P20FY2010RRNIH

Kansas State University, Manhattan KS

Investigators

Linked publications & trials

Paper 35984304 Paper 30670846 Paper 29692861 Paper 29368643 Paper 29155177 Paper 28994389 Paper 28613152 Paper 27806708 Paper 27515813 Paper 26999025 Paper 25942583 Paper 25756513 Paper 25701385 Paper 25599862 Paper 25478909 Paper 25372927 Paper 25056886 Paper 24810589 Paper 24684621 Paper 24561068 Paper 24466141 Paper 24449471 Paper 24432200 Paper 24405031 Paper 24371040 Paper 24363411 Paper 24204943 Paper 24169547 Paper 24129511 Paper 23933333 Paper 23903699 Paper 23874234 Paper 23774898 Paper 23741519 Paper 23676093 Paper 23610747 Paper 23537040 Paper 23527204 Paper 23505020 Paper 23474329 Paper 23420085 Paper 23319456 Paper 23306065 Paper 23301097 Paper 23205322 Paper 23152794 Paper 23151582 Paper 23132805 Paper 23107341 Paper 23034168 Paper 22960307 Paper 22925638 Paper 22889370 Paper 22851751 Paper 22847425 Paper 22827861 Paper 22785210 Paper 22771788 Paper 22750067 Paper 22706317 Paper 22691166 Paper 22685690 Paper 22685498 Paper 22479493 Paper 22447859 Paper 22389453 Paper 22372845 Paper 22355246 Paper 22330721 Paper 22242155 Paper 22200497 Paper 22126696 Paper 22079431 Paper 21986207 Paper 21980520 Paper 21965328 Paper 21957188 Paper 21948195 Paper 21943747 Paper 21930896 Paper 21871098 Paper 21851062 Paper 21757190 Paper 21750018 Paper 21740582 Paper 21647610 Paper 21623837 Paper 21609311 Paper 21423764 Paper 21316749 Paper 21297964 Paper 21284860 Paper 21187447 Paper 21142194 Paper 21104937 Paper 21104926 Paper 21103348 Paper 21056969 Paper 21036704 Paper 21029413

Abstract

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The goal of the study is to provide an adjustable dosage, efficient means of analgesic drug delivery that has low abuse potential, wide therapeutic index, and results in dose-dependent drug absorption. Currently available analgesic patches are subject to patient abuse, have resulted in fatalities, been the subject of abuse, and are only available in fixed dosages

View original record on NIH RePORTER →